Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE1
3 participants
INTERVENTIONAL
2006-09-30
2008-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Light-Therapy in the Treatment of the Acute Phase of the Bipolar Type II Depression
NCT00590265
Change in Brain Bioenergetics in Bipolar Disorder in Response to Photic Stimulation
NCT00801567
Magnetic Resonance-Guided Focused Ultrasound Bilateral Capsulotomy for the Treatment of Refractory Bipolar Depression
NCT07108257
Functional Remediation for Bipolar Disorder
NCT03403179
Family Focused Therapy for Teens at Risk for Bipolar Disorder
NCT02355366
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The excessive brain power, however, had to be controlled occasionally with mood stabilizers. Mood stabilizers include a number of anticonvulsants and Lithium. These medications, however, have adverse side effects on the kidneys. The proposed evaluation does not have any adverse health effects.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Far infrared
Far infrared radiation (5μm to 15μm wavelength)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Far infrared
Far infrared radiation (5μm to 15μm wavelength)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
GAAD Medical Research Institute Inc.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
GAAD Medical research Institute Inc.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kwasi Donyina, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
GAAD Medical Research Institute Inc.
Ken Nedd, M.D.
Role: STUDY_DIRECTOR
GAAD Medical Research Institute Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Centre for Incurable Diseases
Mississauga, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GAAD-BPC-CTP1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.